Inducible (shRNA-mediated) deoxycytidine-kinase (dCK) knock-down confers myeloprotective properties to human hematopoietic in vitro modelsK. Czarnecki,N. Lachmann,M. Hetzel,S. Brennig,N. Heinz,B. Schiedlmeier,T. MoritzHUMAN GENE THERAPY(2013)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要